Articles

81. A Week Of Pharma/Biotech Dealmaking 3/22/2012

    In the new year’s early wake, the JP Morgan Healthcare Conference (JPM HC) spreads over San Francisco’s central downtown blocks, sparking private meetings and satellite seminars in hotels and eateries all around the event site at the St. Francis. By Wayne Koberstein

82. Brochure: Finished Dosage Forms 2/21/2012
    DSM is a global provider of finished dosage form manufacturing and related services to pharmaceutical and biopharmaceutical markets.
83. Persistence Leads To High Enrollment: PRA Convinces Client To Stick With Recruitment Strategies 2/21/2012

    PRA was contracted by a large biotech client to evaluate the immunogenicity of a flu vaccine in adult subjects with rheumatoid arthritis. From the start, the PRA study team faced a shortened enrollment period and other timeline challenges, including the protocol’s late delivery as well as problems with the vaccine’s availability. 

84. Match Your CRO To The Clinical Study 2/13/2012

    The success of companies that rely on outsourcing for the development of new pharma products can be intrinsically linked to the partnership with the CRO. By Cindy Dubin, Life Science Leader magazine

85. Logistics Improving In Emerging Markets 2/13/2012

    Whether there for clinical trials, manufacturing, or market share, life sciences companies entering emerging and developing regions for the first time “tend to overlook the challenges associated with security, regulations, and the unique nature of the supply chain,” notes Bill Hook, VP of global strategy for UPS Healthcare Logistics.

86. Saudi Arabia Emerges As Pharma Manufacturing Hot Spot 2/12/2012

    The World Bank/International Financial Corporation’s Doing Business report ranked the Kingdom of Saudi Arabia 12th in the world out of 183 economies for ease of doing business in 2011 — up from 67th in 2005. By Sara Gambrill, Life Science Leader magazine

87. Track And Trace In China 2/9/2012
    Track and trace technology has significant value for both industry and society. Both Chinese industry and the government are increasing efforts to promote the establishment of a reliable, safe traceability system. By Yuxiang Zhang
88. Brochure: Pharma Sterile Dosage Forms 1/30/2012

    DSM offers pharmaceutical and biopharmaceutical customers a lyophilization system with unique benefits. It has the precision to serve increasingly demanding lyophilization cycles, a critical requirement for successful product launches and high commercial yields. 

89. How To Maximize Returns And Minimize Damage When Closing A Manufacturing Plant 12/22/2011

    In the past 18 months, a number of large pharma companies have announced downsizings and plant closings. Behind the headlines stand billions of dollars in real estate, and laboratory, manufacturing, and packaging equipment that had to be decommissioned, redeployed, or sold. By Karl Schmieder, Life Science Leader magazine

90. NIH, Industry, And The Translational Science Revolution 12/21/2011

    The National Institutes of Health's (NIH's) reputation has been built, in large part, on discoveries made during basic science research — original insights about pathways, receptors, and targets for drugs. These discoveries have led to a significant percentage of new drug approvals in most of the major classes of drugs. By Sara Gambrill, Life Science Leader magazine